Drug intelligence / Profile preview

rose flower

Development stage: Preclinical
Modality: Small Molecules
Administration: Oral

Overview

Rose flower refers to the bloom of the *Rosa* genus, including species like *Rosa hybrida* and *Rosa chinensis*. Extracts from rose flowers are being investigated for various biological activities, including the inhibition of α-glucosidase by polyphenol-rich extracts, and antimicrobial and anticancer effects demonstrated by acetone extracts. The flower is also recognized for its antioxidant properties, attributed to its content of polyphenols, flavonoids, and anthocyanins. It is utilized in edible products and as a source for extracts with potential health-promoting benefits.

Other names: 玫瑰花

Targets

Sucrase-IsomaltasePGN (Peptidoglycan)

Beyond the preview

Go deeper on rose flower.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on rose flower.

Explore the full profile